(NYSE: AVNS) Avanos Medical's forecast annual revenue growth rate of 1.16% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.62%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.27%.
Avanos Medical's revenue in 2026 is $715,900,000.On average, 3 Wall Street analysts forecast AVNS's revenue for 2026 to be $33,910,515,091, with the lowest AVNS revenue forecast at $32,580,690,969, and the highest AVNS revenue forecast at $34,907,883,182.
In 2027, AVNS is forecast to generate $35,343,353,756 in revenue, with the lowest revenue forecast at $33,957,339,884 and the highest revenue forecast at $36,382,864,161.